The use of tobacco products and the harmful side effects of smoking tobacco continue to gain increasing attention worldwide. As more regulations come into effect regarding smoking in the work place or in public, interest in developing alternative products is growing significantly. One method of reducing the harmful side effects of smoking is to not burn the tobacco products. This is because many of the harmful analytes, such as Hoffman analytes, obtained from smoking are received due to the burning of the material.
A difficulty of developing and marketing a device that can deliver an aerosolized tobacco product is catering to the user in terms of visual and physical appeal of use. A device that can be used multiple times to aerosolize a variety of different substances while providing similar sensations to the user as those from smoking, such as visual vapor, are desirable. A device and product that can aerosolize a tobacco product and reduce Hoffman analytes and mutagenic compounds delivered to a user as compared to smoking are also desirable.
In an aspect of the invention, a cartridge is disclosed for use in a device for aerosolizing a material comprising: a shell for containing a viscous vaporizable material; and a lid sealed upon the shell, thereby forming a sealed cartridge containing the viscous vaporizable material. The lid can be penetrable, wherein a penetrated lid allows an exit of an aerosol generated from heating the viscous vaporizable material. The lid can also be a heat-sealable film, wherein the heat-sealable film comprises a base layer and a heat-sealable layer. The shell of the cartridge or the lid of the cartridge can comprise aluminum. When a shell of a cartridge of the invention comprises a flange, a lid can be sealed upon the flange.
The cartridge can be heated to a temperature required to aerosolize the material contained within the shell, preferably heated to a temperature less than 400° F. The viscous vaporizable material within the cartridge can comprise at least one of an aerosol-forming medium, propylene glycol and glycerin. The viscous vaporizable material can comprise tobacco.
The cartridge can be inserted into a device wherein the device is capable of aerosolizing the viscous vaporizable material. The device can comprise an oven chamber capable of heating the cartridge.
In order to mark a cartridge of the invention, information can be printed on at least one of the shell and the lid.
In another aspect, a method of filling a cartridge containing a viscous vaporizable material comprises: loading the viscous vaporizable material into a shell of the cartridge; and sealing a lid on the shell of the cartridge. The method can be automated, for example, carried out on a linear or rotating indexing machine, or loaded using an auger filler, peristaltic pump or piston pump method. A predetermined volume of viscous vaporizable material can be loaded in the loading step, wherein the predetermined volume can be about 0.1 to about 0.8 cubic centimeters. Preferably, the volume is about 0.25 cubic centimeters. The sealing step of a method of filling the cartridge can comprise heating at least one of the lid and the shell of the cartridge and trimming any excess material from the lid.
A device for generating an inhalable aerosol is provided herein comprising: a body; a heater within said body capable of heating a viscous vaporizable material to generate an inhalable aerosol; and temperature regulator comprising one or more bimetallic discs, wherein the discs convert a temperature change into mechanical displacement. The inhalable aerosol can comprise particles less than about 2 microns in diameter. The heater of the device can be supplied by gaseous fuel, such as butane, and can be ignited by a piezoelectric igniter.
The discs of the temperature regulator can displace a pushrod that limits or ceases flow of the gaseous fuel within the body of the device by pushing on a variable flow-restricting valve. The pushrod can also provide support for a catalytic mesh element.
In another aspect, the invention provides a device which emulates smoking wherein the device generates an aerosol for inhalation by a subject by heating a viscous material containing plant matter to about 150° C. and wherein the aerosol has a tactile response in the mouth or respiratory tract. The viscous material can comprise an aerosol-forming medium that can comprise at least one of propylene glycol and glycerin to produce a visual aerosol when heated. The viscous material can also comprise tobacco and flavorants.
The device can also deliver an active element to a user that is part of the aerosol. The active element can be absorbed in the respiratory tract. The aerosol can comprise particles less than about 2 microns in diameter.
Disclosed herein is a device of the invention comprising a body and a heater wherein the device generates a smokeless aerosol for inhalation by a subject by heating a viscous tobacco material to a target temperature. The viscous material can comprise an aerosol-forming medium that can comprise at least one of propylene glycol and glycerin to produce a visual aerosol when heated. The device can deliver an active element to a user that is part of the aerosol. The active element can be absorbed in the respiratory tract. The aerosol can comprise particles less than about 2 microns in diameter.
The target temperature for heating the viscous material in the device can be about 100° C. to about 200° C. Preferably, the target temperature is about 150° C.
The device can also be operated by a user with a single hand.
In another aspect of the invention, an aerosol generating device is disclosed wherein the device generates an aerosol substantially free from at least one Hoffman analyte upon heating a smokable material to a target temperature. The Hoffman analyte can be selected from the group consisting of: ammonia, aminonaphthalenes, benzopyrene, formaldehyde, acetaldehyde, acetone, methyl ethyl ketone, butyraldehyde, hydrogen cyanide, nitrous oxides, tobacco-specific nitrosamines (TSNAs), pyridine, quinoline, hydroquinone, phenol, cresols, tar, nicotine, carbon monoxide, 1,3-butadiene, isoprene, acrylonitrile, benzene, toluene, and styrene.
The target temperature for heating the viscous material in the device can be about 100° C. to about 200° C. Preferably, the target temperature is about 150° C., which generates an aerosol comprising particles less than about 2 microns in diameter.
The invention also provides an aerosol generating device wherein the device generates an aerosol upon heating a smokable material to a target temperature with at least 70% less Hoffman analytes than a common tobacco cigarette, and wherein the Hoffman analyte can be selected from the group consisting of: ammonia, aminonaphthalenes, benzopyrene, formaldehyde, acetaldehyde, acetone, methyl ethyl ketone, butyraldehyde, hydrogen cyanide, nitrous oxides, tobacco-specific nitrosamines (TSNAs), pyridine, quinoline, hydroquinone, phenol, cresols, tar, nicotine, carbon monoxide, 1,3-butadiene, isoprene, acrylonitrile, benzene, toluene, and styrene. The common tobacco cigarette can comprise a filter.
The target temperature for heating the viscous material in the device can be about 100° C. to about 200° C. Preferably, the target temperature is about 150° C. and generates an aerosol comprising particles less than about 2 microns in diameter.
In an aspect, the invention discloses a method of delivering an aerosol substantially free from a Hoffman analyte to a subject comprising: deploying an aerosol generating device containing a heater and a smokable material; heating the smokable material with the heater of the device to a target temperature to generate an aerosol; and delivering the aerosol to the subject for inhalation.
In another aspect, a method of creating a tactile response in the mouth or respiratory tract is disclosed. The method comprises: deploying a smoke emulating device wherein the device generates a smokeless aerosol having a tactile response in the mouth or respiratory tract by heating a viscous material containing plant matter contained therein; heating the viscous material to a target temperature; generating an aerosol having the tactile response in the mouth or respiratory tract from the heated viscous material; and inhaling the aerosol. The viscous material can comprise an aerosol-forming medium that can comprise at least one of propylene glycol and glycerin to produce a visual aerosol when heated. The viscous material can also comprise at least one of tobacco and flavorants. The device can deliver an active element to a user that is part of the aerosol. The active element can be absorbed in the respiratory tract. The aerosol can comprise particles less than about 2 microns in diameter.
In another aspect, the invention discloses an aerosol generating device wherein the device generates an aerosol from a smokable material wherein the aerosol contains at least 70% less Hoffman analytes than a substance generated by burning the smokable material is provided by the invention.
Also disclosed is an aerosol generating device wherein the device generates an aerosol from a smokable material that passes the Ames test, and an aerosol generating device wherein the device generates an aerosol from a smokable material wherein the aerosol scores significantly better on the Ames test than a substance generated by burning the smokable material.
The invention provides an aerosol generating device wherein the device provides an aerosol for inhalation to a user for at least 4 non-continuous hours without replenishing fuel or otherwise servicing the device.
All publications, patents and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference.
A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are used, and the accompanying drawings of which:
The invention described herein has a wide range of applications for inhalation of an active substance as will be appreciated by persons of skill in the art upon reviewing the disclosure. For example, the devices, cartridges, systems, kits and methods could be used, for example, to inhale a tobacco product through the mouth or nose. The devices, cartridge, systems, kits, and methods could also be used to reduce the Hoffmann analytes provided to user by inhaling a tobacco product, as compared to smoking or burning of tobacco. Additionally, the devices, systems, kits and methods could be used, for example, to inhale any substance, such as a botanical, pharmaceutical, nutraceutical, or any other substance providing a benefit or sensation to an end user.
I. Aerosol Generating Device
An exemplary device of the invention is illustrated in
A device can be constructed without an active regulating element. This can result in reduced complexity and in lowering the overall cost of manufacture of the device. For example, the flow of fuel to the heater 122 can be set at a low level. In use, the temperature inside the oven chamber 124 increases until an equilibrium point where additional heat introduced equals the heat lost to the environment. Heat is lost by conduction through the body of the device 100, and with the vapor delivered to the user. This equilibrium point determines the operating temperature of the device 100. By changing the fuel flow rate, size and material of the burner, and other factors, the system can be calibrated to provide a fairly stable desired operating temperature.
A piezo-electric igniter can be used. Other igniters can be used, such as, a flint starter or battery-powered resistive coil.
As illustrated in
The fuel tank can hold enough fuel for repeated uses of the device. The device can be used for up to 10, 20, 30, 40, 50, or 60 uses. In some embodiments, the device can be used for more than 60 uses. The device can also be used for up to 1, 2, 3, 4, 5, 6, 7, or 8 hours of continuous or non-continuous use. A cartridge for use with the device can be disposed after each use or used for multiple uses. The long lasting use of a device of the invention provides the user the advantage of not having to service the device or refill the fuel tank on a regular basis. The advantage of multiple uses can be preferably obtained by using a larger sized fuel tank and/or the use of butane as a fuel, which can produce the necessary temperatures to use the device in an efficient manner.
Typically, the operating temperatures of the device are no more than 200° C. Often the temperature required to aerosolize a product is between about 100 to 200° C. In some embodiments, the temperature required to aerosolize a product is about 150° C. Once the product within the device has been aerosolized, the aerosolized product is provided to a user through a mouthpiece. In many cases, a device of the invention is designed to emulate a smoking device, such as a cigarette, a pipe or a cigar holder.
In
A bimetallic object can be used to convert a temperature change into mechanical displacement. The object comprises two different metals which expand at different rates as they are heated, for example, steel and copper. The object can be an alloy or two metals that have been secured together. The bimetallic objects can be of any planar shape, such as a square, rectangle, or strip. Preferably, the bimetallic objects are bimetallic discs. The different expansions force the flat object to bend one way if heated, and to bend in the opposite direction if cooled. The bimetallic objects can be bimetallic discs such as the commercially available Truflex P675/700 discs.
The mechanical displacement of a bimetallic object is much larger than the small lengthways expansion in either of the two metals. This effect is used in a range of mechanical and electrical devices. In most of the example devices of the invention, the bimetallic object is used in the planar form. In others, it can be wrapped into a coil for compactness.
Nickel titanium (NiTi) is a shape memory alloy also commonly referred as Nitinol. Above its transformation temperature, Nitinol is superelastic and able to withstand a large amount of deformation when a load is applied and return to its original shape when the load is removed. Below its transformation temperature, it displays the shape memory effect. When it is deformed it will remain in that shape until heated above its transformation temperature, at which time it will return to its original shape. Nitinol is typically composed of approximately 55% Nickel by weight. Making small changes in the composition can change the transition temperature of the alloy significantly. These unique properties and tailorability of Nitinol to be used in a wide range of temperatures makes it suitable as substitute for the bimetallic object of the present invention. As will be appreciated by those skilled in the art other shape memory alloys can be used without departing from the scope of the invention.
The use of alternately-stacked bimetallic discs in a device of the invention is not only a simple and cheap solution for fitting a thermal regulation scheme into a very small space, but also has some key advantages over other methods of thermal regulation. The discs are a modular solution, meaning that different numbers of discs can be used to tune the temperature sensitivity of a device. Using multiple discs instead of one disc allows longer overall travel for a given (small) diameter of disk. Thinner or thicker discs can also be used for the same purpose, or to add additional ability to exert force. Since the doming shape of the discs is particularly strong, the varying pressure of the fuel will have minimal effect on the regulation temperature. Also, since the bimetallic stack is a non-discrete, continuously acting system, the device can have a dampened regulation effect by using the roughened-seat design mentioned above, making the device much less likely to self-extinguish. The discs also respond to a temperature at a point nearest the oven of the device so that the oven is held at the most constant temperature possible.
The stopper 544 can be connected to a rigid jetting assembly terminating with an electrically insulating component 546. The jet assembly is normally held in a position that allows gas to exit the valve orifice 542 and to enter the jet assembly by a relatively low spring constant biasing spring 548. Gas is limited to only entering the jet assembly by a sliding seal 550. Alternately, a flexible diaphragm could be used. The user is able to defeat this normal flow of gas by sliding an activating slider so that the jetting assembly is held down such that the stopper 544 seals the valve orifice 542; this is the OFF state of the device 500. When the user allows the normal gas flow state by sliding an activating slider to the ON position a piezo-igniter is depressed so that a spark is generated between the jet rosette 552 and the oven heater 522, thereby igniting the flowing gas. As the oven heater 522 begins to reach its operating temperature a series of alternately stacked bimetal discs 532 change shape (transitioning from flat to domed) and act on a pushrod component 534 which in turn presses the jet assembly so that the stopper 544 limits or ceases the flow of gas.
By using a bimetallic disc design, a device of the invention may be tuned to a specified temperature regulating range by simply changing the distance between the backstop of the discs and the valve seat. In
In
Many devices of the invention use a temperature regulation scheme in that the temperature regulator (bimetallic discs) are located in close proximity to the area where temperature is most critical (at the oven). Related art has typically located the temperature-sensitive component at the flow valve, which can be easily influenced by the cool temperature of expanding fuel gas and has minimally intimate contact with the vaporizing chamber. Examples of related devices and methods are described in U.S. patent application Ser. No. 11/485,168, U.S. Pat. Nos. 4,819,665, 4,793,365, 5,027,836 and PCT Application WO 2006/082571. The regulation scheme of a device of the invention may be tuned to a specific temperature by a simple twist of the oven.
In the exemplary devices of
The user is prevented from touching the hot internal elements by surrounding insulating features. A device of the invention can include insulation for keeping the user from contacting the necessarily hot portion of the device. While greater thermal insulating ability is preferable so that the device performs with the best efficiency possible, an important aspect for the user is to perceive a relatively cool surface temperature. Various strategies can be employed to address the perception of the user regarding the temperature of the device. The device may be wrapped in a thermal insulating material that has enough durability for external use. Materials for this purpose have low thermal conductivity and low thermal capacity (specific heat). The combination of these properties can allow little heat to be transferred to the fingers of the user. Examples of materials with low thermal conductivity and capacity include some polymers and ceramics. A separate strategy is to use standoff features that keep the user from touching the higher temperature area directly. This can also minimize the contact area of the user's fingers and the device to additionally reduce perceived heat. The thermal conductivity and specific heat of the standoff features should be as low as possible.
A heater of a device of the invention can comprise a conductive shell and a catalyst, wherein the shell may be of one or more material formed by welding or pressing together. The catalyst within the heater can be chosen to provide an efficient flameless combustion of the fuel. In some cases, in order to provide a visual clue to the user, the catalyst or heater can emit a color, such as red, when the heater is heating to indicate that the device is activated.
In some cases, the heater can exhaust directly to the surrounding atmosphere through a side aperture. However, as demonstrated in
In the field of combustion catalysts, the light-off temperature is often used to describe the minimum temperature at which the catalyst must be maintained in order to catalyze the exothermic reaction of fuel and oxidant. Only a portion of the catalyst must remain at this temperature to prevent the reaction from extinguishing altogether. The targeted operating temperature of a heater of a device of the invention is close to the light-off temperature of most catalysts, and can make maintaining the catalyst difficult to achieve. The target operating of temperature of the heater can be 180° C. Examples of types of catalysts used in a device of the invention include, but are not limited to, platinum, palladium, and rhodium. The catalyst light-off temperature of a catalyst for use with the invention may be from about 100 to 200° C.
To address the fine difference in temperature of the heater as compared to the light-off temperature a small trickle of gas can flow over the catalyst and/or the catalyst can be shielded from external factors, such as wind. A device of the invention can include a protected exhaust path, meaning that exhaust does not directly exit to the outside air but instead travels along a convoluted path so that the catalyst is difficult to extinguish by wind.
A concern for the reliability of the device of the invention is to maintain catalyst operation at the low target temperatures of the device. A discrete on/off valve alone can have difficulty in this regard because the cycle time between butane bursts can sometimes allow the catalyst to cool to too low of a temperature, and a rapid burst of expanding butane can actually serve to extinguish the catalyst since the butane temperature will be cool. A simple solution that can be incorporated into a device of the invention is to slightly roughen the valve seat surface, or to use a textured stopper surface so that the device can achieve a low-flow of butane just before it closes the flow completely during regulation. This is similar in operation to a needle valve, but much cheaper and easier to implement. A needle valve can also be used in a device of the invention to regulate fuel flow. Some prior art uses a thermal mass so that the light-off temperature can be maintained between regulation intervals. When gas flow resumes between regulation intervals only the area in contact with the thermal mass will initially catalyze the gas, exhausting a reasonable amount of unused fuel. A device of the invention does not require such a thermal mass since the valve seat can act as an analog valve and allow the device to dampen regulation intervals and intensity. A device of the invention can trickle an amount of butane needed to keep the catalyst above light-off temperature, in other words, not overwhelming the catalyst.
As demonstrated in
A device as shown in
A mouthpiece can be made of a high-temperature and food-safe material such as ceramic, glass, or various high-temperature plastics such as polyimide thermoplastic resins, polyetherimide (PEI) resin (brand name Ultem®). Design is simplified by use of high temperature materials, but standard plastics or wood, could also be used with the addition of an insulating component that prevents excessive heat from reaching the user, e.g., the user's lips. Additionally, a mouthpiece can be extended in length, such that the temperature at the mouth of the user is substantially lower than the end of the mouthpiece close to the source of heat.
The mouthpiece 710 of a device 700 of the invention, such as the example in
Some related art devices require two hands for ignition, leading to a clumsy user experience. Preferably a method of ignition using a device of the invention allows for single-handed ignition. As shown in
A device of the invention may also provide additional user friendly advantages. For example, the bimetallic object temperature regulator allows for the device to be of a slim, compact, and thus appealing form. Thermal insulating methods prohibit the user from being startled by high heat. A simple on/off mechanism allows for the user to begin and end the use session using a single hand.
II. Cartridge
Preferably a cartridge formed and shaped for easier insertion into an oven chamber of a device of the invention and to snugly fit into the cavity of the oven chamber for improved thermal conduction and vaporization. Cartridges can be formed and wrapped in a process that does not produce significant amount of harmful gases.
A shell of a cartridge can be lidded with, for example a heat-sealable lidding film, to make a fully enclosed and airtight cartridge. A sealed cartridge of the invention can have the advantage of preserving freshness of the contents, and preventing spill of the materials within the cartridge during shipment or handling by the user.
The lid of a cartridge can also be made by a variety of materials. Typically, the lid comprises a food-safe material. The lid can be sealed onto the cartridge after the moist vaporizable content is inserted into a cartridge of the invention. Many methods of sealing the lid upon the shell of a cartridge are known to those with skill in the art. One example of a method of sealing the lid on a shell of a cartridge comprising a flange is heat sealing. Preferably, the lid of the cartridge is considered food-safe to at least about 400° F. The lid can be a commercially-available film for use with foods cooked in a conventional oven, and are often referred to as dual-ovenable (for microwave and conventional oven use). The dual-ovenable films typically comprise of a PET (polyethylene terephthalate) base layer and an APET (amorphous polyethylene terephthalate) heat-sealing layer. Such lidding films can readily be metallized, or foilized in advance, preferably with aluminum to improve the barrier performance of the film regarding moisture, oxygen and other gases. Metallized films can be produced by common converting processes known to those skilled in the art.
For illustration,
The material of a cartridge of the invention and the shell can serve to preserve the freshness of the fill material, and increase shelf life of the cartridges. A metallized cartridge or lid or shell can also improve the visual appeal and perceived value of the cartridges. The material of the cartridge can also allow for improved printing and visibility of product information such as brand and indication of flavor.
A cartridge 1270 of the invention that contains a moist vaporizable product can have apertures or vents 1288 in the cartridge 1270, as demonstrated by the example cartridge 1270 in
The exemplary cartridge 1270 in
The portions of a cartridge can be of
In many cases, a cartridge of the invention is intended for a single use and to be disposable. However, some types of cartridges, such as those that have methods for sealing two portions together, could be used multiple times as a reusable cartridge.
A cartridge can be provided or sold to an end user containing a single use of a moist vaporizable product. The type of product contained within the cartridge can be stamped or written on the cartridge, or indicated by the color, size, or shape of the cartridge. However, a cartridge can be filled by an end used with a moist vaporizable product.
As intended for use by the end consumer, a sealed cartridge of the invention can be inserted into the oven chamber of the device of the invention. The mouthpiece of the device is then returned to the closed position, at which point it can puncture the film on the top of the cartridge. Vapor generated by the heating process is then allowed to exit the cartridge and be inhaled by the user through the mouthpiece.
III. Aerosolized Materials
Any material that is capable of being aerosolized and inhaled by a user may be incorporated into a device or cartridge of the invention as would be obvious to one skilled in the art. It is of particular interest that the material provides an experience to the user either in terms of tactile response in the respiratory tract, or in terms of visual feedback regarding the exhalation of the inhaled material. For example, many materials have be contemplated for use with the present invention including, but not limited to, those containing tobacco, natural or artificial flavorants, coffee grounds or coffee beans, mint, chamomile, lemon, honey, tea leaves, cocoa, and other non-tobacco alternatives based on other botanicals. A device or cartridge of the invention can also be compatible for use with pharmaceutical compounds or synthetic compounds, either for pharmaceutical or pleasurable use. Any such compound which can be vaporized (or volatized) at a relatively low temperature and without harmful degradation products can be suitable for use with a cartridge or device of the invention. Examples of compounds include, but are not limited to, menthol, caffeine, taurine, and nicotine.
Active elements contained in botanicals vaporize at different temperatures. The device can be calibrated to establish a single stable temperature, intended for vaporizing specific products, for example. A controller can also be used to select a variety of temperature settings. The user would choose which setting based on the type of cartridge used. The controller can also affect a desired temperature mechanically, such as by changing flow rate of the valve, or electronically, such as by electromechanical valve and micro-controller intermediary. For example, to change the operating temperature of a device of the invention, the oven chamber can be moved in respect to the temperature regulator, such as bimetallic discs.
Here, tobacco or tobacco material is defined as any combination of natural and synthetic material that can be vaporized for pleasure or medicinal use. In one embodiment of the present invention, a cartridge can be prepared using cured tobacco, glycerin, and flavorings. Those skilled in the art of tobacco product manufacture are familiar with these and other ingredients used for cigarettes, cigars, and the like. The cartridge can be produced by chopping tobacco into fine pieces (for example, less than 2 mm diameter, preferably less than 1 mm), adding the other ingredients, and mixing until even consistency was achieved. In another embodiment, a cartridge can be prepared by processing the fill material into an even paste-like consistency (for example, particle size less than 1 mm), which facilitates the processing of filling the cartridge, for example, by use of an auger filler, peristaltic pump or a piston pump.
Preferably the material for use with a device of the invention or contained within a cartridge of the invention comprises at least one of a vapor-forming medium and a medium for providing a tactile response in a respiratory tract of a user. The aerosolized product from the material inserted into a device can be a combination of vapor phase gases as well as small droplets which have condensed out of vapor phase and remain suspended in the gas/air mixture (the latter constitutes the visible portion of the inhaled substance).
Propylene glycol (PG), glycerin, or a combination of both can be used as vapor-forming medium. Other vapor-forming media can be used with a cartridge and device of the invention. The vapor-forming medium serves to produce a visual vapor, such as a smoke-like vapor, when heated. This vapor can be visualized both before inhalation and during exhalation of the medium. PG has some advantages as compared to glycerin alone, as it exhibits a much higher vapor pressure at equivalent temperature and allows the device to operate at a lower temperature. Reducing the operating temperature conserves energy, and potentially can further improve the health benefits of using this system.
In some cases, vapor resulting from PG that is inhaled by the user can partially absorb in the respiratory tract. If this occurs, it can appear as though the user is expelling primarily air. This differs from the conventional smoking experience in that in the case of smoking, users can typically see and play with expelled smoke as they exhale. Because the visual vapor created by heating glycerin can be seen upon exhale, some preparation of fill material for this invention can comprise a combination of both glycerin and PG. In these embodiments, the PG allows for high densities of visual vapor which the user can see/experience prior to inhaling as well as a tactile response in the respiratory tract, and the addition of glycerin allows for increased amounts of vapor to be seen or otherwise experienced upon exhale.
One method of manufacturing the material for use in a device or cartridge of the invention is to combine cured tobacco leaves with the other ingredients at low heat, and then allow the mixture to incorporate or marinate at room temperature for an extended period of time, from one day to as long as three weeks (depending on the particular recipe and flavors used). The material can then processed by chopping into even consistency with particles 1-2 mm in diameter and inserted into the cartridge, or directly into the device. Alternatively, the material can be processed into a more even, paste-like consistency for improved handling in conventional pump equipment, as described herein.
Example methods of filling a material into a cartridge included an auger fill method and a piston pump method. Both of these are common fill processes used in the packing industry for food and pharmaceutical goods. Either method allows for loading a repeatedly controlled volume of fill material (for example, about 0.25 cubic centimeters) into the shell. The filled shell can then be lidded using the heat-sealable lidding film. The fill and seal operations can be combined on an indexing machine known to those skilled in the art of food and pharmaceutical packaging.
IV. Uses
The device can emulate smoking by providing many of the desirable effects of smoking required by a user. An example of a method of use of a device and/or cartridge of the invention is demonstrated in
Also, when smoking a tobacco material, the smoke may provide a visual aide and/or visual recognition to the user. In order to provide a similar visual aide, the vapor-forming medium may contain a substance, such as glycerin, that can be visualized before and during inhalation, as well as during exhalation. In an exemplary method of use demonstrated in
V. Hoffman Analytes
Cigarette smoke is a complex mixture of thousands of chemical constituents. Many of these have been linked to smoking-related illnesses. A standard reference on the more harmful compounds found in cigarette smoke is the Hoffmann analytes list recognizing about 44 different analytes that may be present in mainstream smoke. It is named in honor of Dietrich Hoffmann, a biochemist and leading authority on tobacco carcinogenesis. This list contains chemicals commonly associated with the health risks of smoking. These analytes and chemicals include, for instance, ammonia, aminonaphthalenes, benzopyrene, formaldehyde, acetaldehyde, acetone, methyl ethyl ketone, butyraldehyde, hydrogen cyanide, nitrous oxides, tobacco-specific nitrosamines (TSNAs), pyridine, quinoline, hydroquinone, phenol, cresols, tar, nicotine, carbon monoxide, 1,3-butadiene, isoprene, acrylonitrile, benzene, toluene, styrene, and various others. It has been determined that some Hoffmann analytes may be unwanted in the mainstream smoke from a smoking article. As such, extensive research has been conducted on reducing Hoffmann analytes. The Hoffmann analytes may also be carcinogenic and a device for smoking or emulating smoking would be desirable.
Using a device of the invention, a tobacco material can be aerosolized without burning the material. By aerosolizing the tobacco, many of the unwanted chemicals and Hoffmann analytes are not inhaled by the user. For example, a device of the invention can reduce the inhalation of Hoffmann analytes by about 70% or more. In some embodiments, a device of the invention can reduce the inhalation of Hoffmann analytes by about 50% or more. In some embodiments, a device of the invention can reduce the inhalation of Hoffmann analytes by about 60% or more. In some embodiments, a device of the invention can reduce the inhalation of Hoffmann analytes by about 70% or more. In some embodiments, a device of the invention can reduce the inhalation of Hoffmann analytes by about 80% or more. In some embodiments, a device of the invention can reduce the inhalation of Hoffmann analytes by about 90% or more.
VI. Ames Assay
The bacterial reverse mutation test was originally developed by Ames et al. The Ames assay serves as a predictor for compounds that might cause carcinogenesis in humans. The method has been widely adopted, and the FDA incorporates it as part of a more comprehensive study of toxicity for new food additives and drugs. The same test has been widely used to study the toxicity of tobacco products and tobacco smoke. The Ames test is a biological assay to assess the mutagenic potential of chemical compounds. As cancer is often linked to DNA damage, the test also serves as a quick assay to estimate the carcinogenic potential of a compound. In comparison, the standard tests for carcinogenicity done on rodents take years to complete and are expensive. The Ames test uses several strains of the bacterium Salmonella typhimurium that carry mutations in genes involved in histidine synthesis, so that they require histidine for growth. The variable being tested is the mutagen's ability to cause a reversion to growth on a histidine-free medium. The tester strains are specially constructed to have both frameshift and point mutations in the genes required to synthesize histidine, which allows for the detection of mutagens acting via different mechanisms. Some compounds are quite specific, causing reversions in just one or two strains. The tester strains also carry mutations in the genes responsible for lipopolysaccharide synthesis, making the cell wall of the bacteria more permeable, and in the excision repair system to make the test more sensitive. Rat liver extract is added to simulate the effect of metabolism, as some compounds, like benzopyrene, are not mutagenic themselves but their metabolic products are. In order to perform an assay, the bacteria are spread on an agar plate with a small amount of histidine. This small amount of histidine in the growth medium allows the bacteria to grow for an initial time and have the opportunity to mutate. When the histidine is depleted, only bacteria that have mutated to gain the ability to produce histidine will survive. The plate is incubated for 48 hours. The mutagenicity of a substance is proportional to the number of colonies observed.
As demonstrated in Example 2 below, device of the invention for use with a tobacco containing material can show significant improvement in Ames assay results as compared to many types of smoking tobacco. Thus, a device of the invention can provide many of the substances of the tobacco, such as nicotine, to a user while not providing some key carcinogenic components that are associated with the burning or smoke of tobacco.
Cigarette smoke is a complex mixture of thousands of chemical constituents. Many of these have been linked to smoking-related illnesses. The Hoffman analytes list is a standard reference on the more harmful compounds found in cigarette smoke. A set of 52 target compounds will be selected based on the Hoffman list. It is expected that the vapor produced by a device of the invention will reduce the levels of these target compounds by a significant amount (70% reduction or greater).
Constituent testing of a prototype device of the invention and a reference cigarette (KY2R4F) will be conducted in a laboratory. Samples from both types of devices will be acquired onsite, in automated smoking machines and under the Canadian Intense regime (55 cubic centimeter (cc) puffs every 30 seconds). It is believed that this method approximates actual smoking conditions better than the FTC regime (35 cc puffs every 60 seconds). Arista has developed extensive protocols for the analysis of the target compounds, based on literature. These protocols will be employed for testing. Methods of collection and extraction for each group of analyte are summarized in TABLE 1.
For each target compound, five replicate tests will be run, both for a device of the invention and the reference cigarette. The differences in mean yield between the two articles will be determined as a percentage. It is expected that a device of the invention will reduce the level of Hoffman analytes by about 70% or more as compared to the reference cigarette.
The bacterial reverse mutation test, or “Ames assay,” serves as a predictor for compounds that might cause carcinogenesis in humans. This test has been widely used to study the toxicity of tobacco products and tobacco smoke. The objective of this study described here was to screen the smoke condensate of the present invention for mutagenicity in the TA 98 strain of the bacterium Salmonella typhimurium using the Ames assay. Strain TA 98 was chosen because it is among the most sensitive strains of Salmonella typhimurium, and can detect a wide variety of mutagens. If a dose-dependent response is detected, the smoke condensate is considered to be mutagenic for that strain.
Testing Facility.
Test article preparation (i.e., “smoking” and extraction), chemical constituent analysis and genotoxicity were conducted at Arista Laboratories, 1941 Reymet Road, Richmond, Va. 23237.
Preparation of Extracts of Test Articles.
Three cartridges were “smoked” per each replicate using a smoking device of the present invention connected to an automated rotary smoking machine (Borgwaldt RM-20 CSR) using the following parameters: 1) puff volume of 55 ml; and 2) puff duration of 30 seconds and an air flow according to ISO standards. Total Particulate Matter (TPM) phase was collected onto a 44 mm Cambridge filter pad and extracted into dimethyl sulfoxide (DMSO). Immediately following extraction, TPM samples were aliquoted into individual amber vials and stored at less than or equal to −70° C. for greater than or equal to 48 h prior to testing by the Ames assay. Once thawed and used for testing, TPM extracts were not reused or refrozen.
Mutagenicity Testing (Ames Assay).
The Ames assay was conducted on TPM extracts generated during three independent “smoking” sessions. The assay was performed according to according to Arista Standard Operating Procedure #TOX 001. TPM samples were tested in triplicate with the addition of an exogenous metabolic activation system (S9). For each replicate sample, ten concentrations of particulate phase ranging from 0-2000 μg TPM per plate were tested in a minimum of three plates per concentration. Concurrent testing of strain-specific positive controls (with and without S9) and a single concentration (i.e., 100 μg) of the KY2R4F reference cigarette condensate were conducted. The assay was conducted according to Health Canada Official Method 501, second edition, 2004-11-01, Arista Standard Operating Procedure #TOX 001. Results of the Ames assay are shown in
Results.
As shown in
Although preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein can be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.
This application is a continuation of U.S. application Ser. No. 14/625,042, filed Feb. 18, 2015, now issued as U.S. Pat. No. 10,231,484, which is a continuation of U.S. application Ser. No. 12/336,439, filed Dec. 16, 2008, now issued as U.S. Pat. No. 8,991,402, which claims the benefit of U.S. Provisional Application No. 61/014,690, filed Dec. 18, 2007, the disclosures of which are incorporated herein by reference in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
374584 | Cook | Dec 1887 | A |
576653 | Bowlby | Feb 1897 | A |
595070 | Oldenbusch | Dec 1897 | A |
720007 | Dexter | Feb 1903 | A |
799844 | Fuller | Sep 1905 | A |
968160 | Johnson | Aug 1910 | A |
969076 | Pender | Aug 1910 | A |
1067531 | MacGregor | Jul 1913 | A |
1163183 | Stoll | Dec 1915 | A |
1299162 | Fisher | Apr 1919 | A |
1505748 | Louis | Aug 1924 | A |
1552877 | Phillipps et al. | Sep 1925 | A |
1632335 | Hiering | Jun 1927 | A |
1706244 | Louis | Mar 1929 | A |
1845340 | Ritz | Feb 1932 | A |
1972118 | McDill | Sep 1934 | A |
1998683 | Montgomery | Apr 1935 | A |
2031363 | Elof | Feb 1936 | A |
2039559 | Segal | May 1936 | A |
2104266 | McCormick | Jan 1938 | A |
2159698 | Harris et al. | May 1939 | A |
2177636 | Coffelt et al. | Oct 1939 | A |
2195260 | Rasener | Mar 1940 | A |
2231909 | Hempal | Feb 1941 | A |
2327120 | McCoon | Aug 1943 | A |
2460427 | Musselman et al. | Feb 1949 | A |
2483304 | Rudolf | Sep 1949 | A |
2502561 | Ludwig | Apr 1950 | A |
2765949 | Swan | Oct 1956 | A |
2830597 | Kummli | Apr 1958 | A |
2860638 | Bartolomeo | Nov 1958 | A |
2897958 | Tarleton et al. | Aug 1959 | A |
2935987 | Ackerbauer | May 1960 | A |
3146937 | Joseph | Sep 1964 | A |
3258015 | Ellis et al. | Jun 1966 | A |
3271719 | Ovshinsky | Sep 1966 | A |
3292634 | Beucler | Dec 1966 | A |
3373915 | Anderson et al. | Mar 1968 | A |
3420360 | Young | Jan 1969 | A |
3443827 | Acker et al. | May 1969 | A |
3456645 | Brock | Jul 1969 | A |
3479561 | Janning | Nov 1969 | A |
3565071 | Cobb et al. | Feb 1971 | A |
3567014 | Feigelman | Mar 1971 | A |
3675661 | Weaver | Jul 1972 | A |
3707017 | Paquette | Dec 1972 | A |
3792704 | Parker | Feb 1974 | A |
3815597 | Goettelman | Jun 1974 | A |
3861523 | Fountain et al. | Jan 1975 | A |
3941300 | Troth | Mar 1976 | A |
4020853 | Nuttall | May 1977 | A |
4036224 | Choporis et al. | Jul 1977 | A |
4049005 | Hernandez et al. | Sep 1977 | A |
4066088 | Ensor | Jan 1978 | A |
4207976 | Herman | Jun 1980 | A |
4215708 | Bron | Aug 1980 | A |
4219032 | Tabatznik et al. | Aug 1980 | A |
4303083 | Burruss, Jr. | Dec 1981 | A |
4399349 | Deming et al. | Aug 1983 | A |
4506683 | Cantrell et al. | Mar 1985 | A |
4519319 | Howlett | May 1985 | A |
4520938 | Finke | Jun 1985 | A |
4571485 | Spector | Feb 1986 | A |
4579858 | Femo et al. | Apr 1986 | A |
4595024 | Greene et al. | Jun 1986 | A |
4597961 | Etscom | Jul 1986 | A |
4619297 | Kocher | Oct 1986 | A |
4648393 | Landis et al. | Mar 1987 | A |
4651770 | Denham et al. | Mar 1987 | A |
4708151 | Shelar | Nov 1987 | A |
4735217 | Gerth et al. | Apr 1988 | A |
4745705 | Yamamoto et al. | May 1988 | A |
4771796 | Myer | Sep 1988 | A |
4793365 | Sensabaugh, Jr. et al. | Dec 1988 | A |
4794323 | Zhou et al. | Dec 1988 | A |
4798310 | Kasai et al. | Jan 1989 | A |
4810854 | Jursich et al. | Mar 1989 | A |
4813536 | Willis | Mar 1989 | A |
4818843 | Swiatosz | Apr 1989 | A |
4819665 | Roberts et al. | Apr 1989 | A |
4830028 | Lawson et al. | May 1989 | A |
4836224 | Lawson et al. | Jun 1989 | A |
4846199 | Rose | Jul 1989 | A |
4848374 | Chard et al. | Jul 1989 | A |
4848563 | Robbins | Jul 1989 | A |
4870748 | Hensgen et al. | Oct 1989 | A |
4893639 | White | Jan 1990 | A |
4907606 | Lilja et al. | Mar 1990 | A |
4941483 | Ridings et al. | Jul 1990 | A |
4944317 | Thal | Jul 1990 | A |
4945448 | Bremenour et al. | Jul 1990 | A |
4947874 | Brooks et al. | Aug 1990 | A |
4947875 | Brooks et al. | Aug 1990 | A |
4990939 | Sekiya et al. | Feb 1991 | A |
4993436 | Bloom, Jr. | Feb 1991 | A |
5005759 | Bouche | Apr 1991 | A |
5020548 | Farrier et al. | Jun 1991 | A |
5027836 | Shannon et al. | Jul 1991 | A |
5031646 | Lippiello et al. | Jul 1991 | A |
5050621 | Creighton et al. | Sep 1991 | A |
5060671 | Counts et al. | Oct 1991 | A |
5065776 | Lawson et al. | Nov 1991 | A |
5076297 | Farrier et al. | Dec 1991 | A |
5105831 | Banerjee et al. | Apr 1992 | A |
5105838 | White et al. | Apr 1992 | A |
5123530 | Lee | Jun 1992 | A |
5133368 | Neumann et al. | Jul 1992 | A |
5144962 | Counts et al. | Sep 1992 | A |
5152456 | Ross et al. | Oct 1992 | A |
5175791 | Muderlak et al. | Dec 1992 | A |
5183062 | Clearman et al. | Feb 1993 | A |
5224498 | Deevi et al. | Jul 1993 | A |
5240012 | Ehrman et al. | Aug 1993 | A |
5249586 | Morgan et al. | Oct 1993 | A |
5261424 | Sprinkel, Jr. | Nov 1993 | A |
5269237 | Baker et al. | Dec 1993 | A |
5269327 | Counts et al. | Dec 1993 | A |
5303720 | Banerjee et al. | Apr 1994 | A |
5322075 | Deevi et al. | Jun 1994 | A |
5324498 | Streusand et al. | Jun 1994 | A |
5345951 | Serrano et al. | Sep 1994 | A |
5372148 | McCafferty et al. | Dec 1994 | A |
5388574 | Ingebrethsen | Feb 1995 | A |
5388594 | Counts et al. | Feb 1995 | A |
5449078 | Akers | Sep 1995 | A |
5456269 | Kollasch | Oct 1995 | A |
5497791 | Bowen et al. | Mar 1996 | A |
5529078 | Rehder et al. | Jun 1996 | A |
5579934 | Buono | Dec 1996 | A |
5591368 | Fleischhauer et al. | Jan 1997 | A |
5605226 | Hernlein | Feb 1997 | A |
5610635 | Murray et al. | Mar 1997 | A |
5626866 | Ebert et al. | May 1997 | A |
5641064 | Goserud | Jun 1997 | A |
5649552 | Cho et al. | Jul 1997 | A |
5666977 | Higgins et al. | Sep 1997 | A |
5666978 | Counts et al. | Sep 1997 | A |
5708258 | Counts et al. | Jan 1998 | A |
5730118 | Hermanson | Mar 1998 | A |
5730158 | Collins et al. | Mar 1998 | A |
5746587 | Racine et al. | May 1998 | A |
5810164 | Rennecamp | Sep 1998 | A |
5819756 | Mielordt | Oct 1998 | A |
5825975 | Privas | Oct 1998 | A |
5842601 | Pierpoint | Dec 1998 | A |
5845649 | Saito et al. | Dec 1998 | A |
5865185 | Collins et al. | Feb 1999 | A |
5865186 | Volsey, II | Feb 1999 | A |
5881884 | Podosek | Mar 1999 | A |
5919004 | Christenson | Jul 1999 | A |
5931828 | Durkee | Aug 1999 | A |
5934289 | Watkins et al. | Aug 1999 | A |
5938018 | Keaveney et al. | Aug 1999 | A |
5944025 | Cook et al. | Aug 1999 | A |
5954979 | Counts et al. | Sep 1999 | A |
5967310 | Hill | Oct 1999 | A |
5975415 | Zehnal | Nov 1999 | A |
5979460 | Matsumura | Nov 1999 | A |
5991507 | Bencsits | Nov 1999 | A |
5994025 | Iwasa et al. | Nov 1999 | A |
5996589 | St. Charles | Dec 1999 | A |
6053176 | Adams et al. | Apr 2000 | A |
6089857 | Matsuura et al. | Jul 2000 | A |
6095153 | Kessler et al. | Aug 2000 | A |
6098632 | Turner et al. | Aug 2000 | A |
6102036 | Slutsky et al. | Aug 2000 | A |
6119684 | Noehl et al. | Sep 2000 | A |
6125853 | Susa et al. | Oct 2000 | A |
6155268 | Takeuchi | Dec 2000 | A |
6155423 | Katzner et al. | Dec 2000 | A |
6164287 | White | Dec 2000 | A |
6196218 | Voges | Mar 2001 | B1 |
6196232 | Chkadua | Mar 2001 | B1 |
6234169 | Bulbrook et al. | May 2001 | B1 |
6269966 | Pallo et al. | Aug 2001 | B1 |
6324261 | Merte | Nov 2001 | B1 |
6349728 | Pham | Feb 2002 | B1 |
6381739 | Bretemitz, Jr. et al. | Apr 2002 | B1 |
6386371 | Parsons | May 2002 | B1 |
6431363 | Hacker | Aug 2002 | B1 |
6446793 | Layshock | Sep 2002 | B1 |
6450419 | Martens et al. | Sep 2002 | B1 |
6510982 | White et al. | Jan 2003 | B2 |
6513524 | Storz | Feb 2003 | B1 |
6532965 | Abhulimen et al. | Mar 2003 | B1 |
6536442 | St. Charles et al. | Mar 2003 | B2 |
6557708 | Polacco | May 2003 | B2 |
6598607 | Adiga et al. | Jul 2003 | B2 |
6603924 | Brown et al. | Aug 2003 | B2 |
6606998 | Gold | Aug 2003 | B1 |
6612404 | Sweet et al. | Sep 2003 | B2 |
6615840 | Fournier et al. | Sep 2003 | B1 |
6622867 | Menceles | Sep 2003 | B2 |
6655379 | Clark et al. | Dec 2003 | B2 |
6672762 | Faircloth et al. | Jan 2004 | B1 |
6688313 | Wrenn et al. | Feb 2004 | B2 |
6708846 | Fuchs et al. | Mar 2004 | B1 |
6726006 | Funderburk et al. | Apr 2004 | B1 |
6772756 | Shayan | Aug 2004 | B2 |
6799576 | Farr | Oct 2004 | B2 |
6803545 | Blake et al. | Oct 2004 | B2 |
6805545 | Slaboden | Oct 2004 | B2 |
6810883 | Felter et al. | Nov 2004 | B2 |
6827573 | St. Charles et al. | Dec 2004 | B2 |
6909840 | Harwig et al. | Jun 2005 | B2 |
6954979 | Logan | Oct 2005 | B2 |
7000775 | Gelardi et al. | Feb 2006 | B2 |
7015796 | Snyder | Mar 2006 | B2 |
7043147 | Friedheim | May 2006 | B1 |
7290549 | Banerjee et al. | Nov 2007 | B2 |
7434584 | Steinberg | Oct 2008 | B2 |
7488171 | St. Charles et al. | Feb 2009 | B2 |
D590990 | Hon | Apr 2009 | S |
D590991 | Hon | Apr 2009 | S |
7546703 | Johnske et al. | Jun 2009 | B2 |
7621403 | Althoff et al. | Nov 2009 | B2 |
7644823 | Gelardi et al. | Jan 2010 | B2 |
7726320 | Robinson et al. | Jun 2010 | B2 |
7767698 | Warchol et al. | Aug 2010 | B2 |
7784459 | Abrams | Aug 2010 | B2 |
7793860 | Bankers et al. | Sep 2010 | B2 |
7793861 | Bankers et al. | Sep 2010 | B2 |
7801573 | Yazdi et al. | Sep 2010 | B2 |
7802569 | Yeates et al. | Sep 2010 | B2 |
7815332 | Smith | Oct 2010 | B1 |
7832410 | Hon | Nov 2010 | B2 |
7886507 | McGuinness, Jr. | Feb 2011 | B2 |
7913686 | Hughes et al. | Mar 2011 | B2 |
7913688 | Cross et al. | Mar 2011 | B2 |
7988034 | Pezzoli | Aug 2011 | B2 |
8042550 | Urtsev et al. | Oct 2011 | B2 |
8156944 | Han | Apr 2012 | B2 |
8251060 | White et al. | Aug 2012 | B2 |
8322350 | Lipowicz | Dec 2012 | B2 |
8371310 | Brenneise | Feb 2013 | B2 |
8375957 | Hon | Feb 2013 | B2 |
8381739 | Gonda | Feb 2013 | B2 |
8387612 | Damani et al. | Mar 2013 | B2 |
8434478 | Yamada et al. | May 2013 | B2 |
8511318 | Hon | Aug 2013 | B2 |
8541401 | Mishra et al. | Sep 2013 | B2 |
8671952 | Winterson et al. | Mar 2014 | B2 |
8689789 | Andrus et al. | Apr 2014 | B2 |
8733345 | Siller | May 2014 | B2 |
8741348 | Hansson et al. | Jun 2014 | B2 |
8809261 | Elsohly et al. | Aug 2014 | B2 |
8851081 | Fernando et al. | Oct 2014 | B2 |
8915254 | Monsees et al. | Dec 2014 | B2 |
8925555 | Monsees et al. | Jan 2015 | B2 |
8991402 | Bowen et al. | Mar 2015 | B2 |
9155848 | Emarlou | Oct 2015 | B2 |
9215895 | Bowen et al. | Dec 2015 | B2 |
9772216 | Poole et al. | Sep 2017 | B2 |
10231484 | Bowen et al. | Mar 2019 | B2 |
10244793 | Monsees et al. | Apr 2019 | B2 |
20010015209 | Zielke | Aug 2001 | A1 |
20010032643 | Hochrainer et al. | Oct 2001 | A1 |
20010032795 | Weinstein et al. | Oct 2001 | A1 |
20010052480 | Kawaguchi et al. | Dec 2001 | A1 |
20020059939 | Fox | May 2002 | A1 |
20020071664 | Aronie et al. | Jun 2002 | A1 |
20020078951 | Nichols et al. | Jun 2002 | A1 |
20020154903 | Glucksman et al. | Oct 2002 | A1 |
20020158351 | Wohrle | Oct 2002 | A1 |
20020175164 | Dees et al. | Nov 2002 | A1 |
20030005926 | Jones et al. | Jan 2003 | A1 |
20030063901 | Gu et al. | Apr 2003 | A1 |
20030089377 | Hajaligol et al. | May 2003 | A1 |
20030150451 | Shayan | Aug 2003 | A1 |
20030154991 | Fournier et al. | Aug 2003 | A1 |
20030215335 | Crivelli | Nov 2003 | A1 |
20040021017 | Sumiyoshi et al. | Feb 2004 | A1 |
20040031495 | Steinberg | Feb 2004 | A1 |
20040050382 | Goodchild | Mar 2004 | A1 |
20040099266 | Cross et al. | May 2004 | A1 |
20040149296 | Rostami et al. | Aug 2004 | A1 |
20040149624 | Wischusen et al. | Aug 2004 | A1 |
20040173229 | Crooks et al. | Sep 2004 | A1 |
20040182403 | Andersson et al. | Sep 2004 | A1 |
20040221857 | Dominguez | Nov 2004 | A1 |
20040237974 | Min | Dec 2004 | A1 |
20050016549 | Banerjee et al. | Jan 2005 | A1 |
20050016550 | Katase | Jan 2005 | A1 |
20050019026 | Wang et al. | Jan 2005 | A1 |
20050034723 | Bennett et al. | Feb 2005 | A1 |
20050061759 | Doucette | Mar 2005 | A1 |
20050067503 | Katase | Mar 2005 | A1 |
20050069831 | St. Charles et al. | Mar 2005 | A1 |
20050090798 | Clark et al. | Apr 2005 | A1 |
20050118545 | Wong | Jun 2005 | A1 |
20050145533 | Seligson | Jul 2005 | A1 |
20050150488 | Dave | Jul 2005 | A1 |
20050172976 | Newman et al. | Aug 2005 | A1 |
20050244521 | Strickland et al. | Nov 2005 | A1 |
20050266365 | Xie | Dec 2005 | A1 |
20050268911 | Cross et al. | Dec 2005 | A1 |
20050279350 | Rasor et al. | Dec 2005 | A1 |
20050279353 | Mccoy | Dec 2005 | A1 |
20050285538 | Jaworski et al. | Dec 2005 | A1 |
20060018840 | Lechuga-Ballesteros et al. | Jan 2006 | A1 |
20060054676 | Wischusen | Mar 2006 | A1 |
20060102175 | Nelson | May 2006 | A1 |
20060150991 | Lee | Jul 2006 | A1 |
20060191546 | Takano et al. | Aug 2006 | A1 |
20060191548 | Strickland et al. | Aug 2006 | A1 |
20060196505 | Izuchukwu | Sep 2006 | A1 |
20060196518 | Hon | Sep 2006 | A1 |
20060207466 | Mcnulty et al. | Sep 2006 | A1 |
20060211279 | He et al. | Sep 2006 | A1 |
20060254948 | Herbert et al. | Nov 2006 | A1 |
20060255105 | Sweet | Nov 2006 | A1 |
20070006889 | Kobal et al. | Jan 2007 | A1 |
20070014549 | Demarest et al. | Jan 2007 | A1 |
20070045288 | Nelson | Mar 2007 | A1 |
20070062548 | Horstmann et al. | Mar 2007 | A1 |
20070074734 | Braunshteyn et al. | Apr 2007 | A1 |
20070098148 | Sherman | May 2007 | A1 |
20070102013 | Adams et al. | May 2007 | A1 |
20070119450 | Wharton et al. | May 2007 | A1 |
20070144514 | Yeates et al. | Jun 2007 | A1 |
20070163610 | Lindell et al. | Jul 2007 | A1 |
20070215164 | Mehio | Sep 2007 | A1 |
20070235046 | Gedevanishvili | Oct 2007 | A1 |
20070267031 | Hon | Nov 2007 | A1 |
20070267033 | Mishra et al. | Nov 2007 | A1 |
20070277816 | Morrison et al. | Dec 2007 | A1 |
20070280652 | Williams | Dec 2007 | A1 |
20070283972 | Monsees et al. | Dec 2007 | A1 |
20080000763 | Cove | Jan 2008 | A1 |
20080023003 | Rosenthal | Jan 2008 | A1 |
20080029095 | Esser | Feb 2008 | A1 |
20080056691 | Wingo et al. | Mar 2008 | A1 |
20080092912 | Robinson et al. | Apr 2008 | A1 |
20080105257 | Klasek et al. | May 2008 | A1 |
20080138423 | Gonda | Jun 2008 | A1 |
20080149118 | Oglesby et al. | Jun 2008 | A1 |
20080216828 | Wensley et al. | Sep 2008 | A1 |
20080241255 | Rose et al. | Oct 2008 | A1 |
20080257367 | Paterno et al. | Oct 2008 | A1 |
20080276947 | Martzel | Nov 2008 | A1 |
20080302375 | Andersson et al. | Dec 2008 | A1 |
20090004249 | Gonda | Jan 2009 | A1 |
20090032034 | Steinberg | Feb 2009 | A1 |
20090074407 | Hornbuckle et al. | Mar 2009 | A1 |
20090095287 | Emarlou | Apr 2009 | A1 |
20090111287 | Lindberg et al. | Apr 2009 | A1 |
20090126745 | Hon | May 2009 | A1 |
20090126746 | Strickland et al. | May 2009 | A1 |
20090133691 | Yamada et al. | May 2009 | A1 |
20090133703 | Strickland et al. | May 2009 | A1 |
20090133704 | Strickland et al. | May 2009 | A1 |
20090151717 | Bowen et al. | Jun 2009 | A1 |
20090230117 | Fernando et al. | Sep 2009 | A1 |
20090255534 | Paterno | Oct 2009 | A1 |
20090260641 | Monsees et al. | Oct 2009 | A1 |
20090260642 | Monsees et al. | Oct 2009 | A1 |
20090267252 | Ikeyama | Oct 2009 | A1 |
20090272379 | Thorens et al. | Nov 2009 | A1 |
20090283103 | Nielsen et al. | Nov 2009 | A1 |
20090288668 | Inagaki | Nov 2009 | A1 |
20090288669 | Hutchens | Nov 2009 | A1 |
20090293892 | Williams et al. | Dec 2009 | A1 |
20090293895 | Axelsson et al. | Dec 2009 | A1 |
20100000672 | Fogle | Jan 2010 | A1 |
20100006092 | Hale et al. | Jan 2010 | A1 |
20100024834 | Oglesby et al. | Feb 2010 | A1 |
20100031968 | Sheikh et al. | Feb 2010 | A1 |
20100163063 | Fernando et al. | Jul 2010 | A1 |
20100186757 | Crooks et al. | Jul 2010 | A1 |
20100236562 | Hearn et al. | Sep 2010 | A1 |
20100242976 | Katayama et al. | Sep 2010 | A1 |
20100260491 | Pitz et al. | Oct 2010 | A1 |
20100275938 | Roth et al. | Nov 2010 | A1 |
20110036346 | Cohen et al. | Feb 2011 | A1 |
20110049226 | Moreau et al. | Mar 2011 | A1 |
20110094523 | Thorens et al. | Apr 2011 | A1 |
20110108023 | McKinney et al. | May 2011 | A1 |
20110192397 | Saskar et al. | Aug 2011 | A1 |
20110226236 | Buchberger | Sep 2011 | A1 |
20110226266 | Tao | Sep 2011 | A1 |
20110232654 | Mass | Sep 2011 | A1 |
20110236002 | Oglesby et al. | Sep 2011 | A1 |
20120247494 | Oglesby et al. | Oct 2012 | A1 |
20120255567 | Rose et al. | Oct 2012 | A1 |
20120260927 | Liu | Oct 2012 | A1 |
20130042865 | Monsees et al. | Feb 2013 | A1 |
20130068239 | Youn | Mar 2013 | A1 |
20130081642 | Safari | Apr 2013 | A1 |
20130152922 | Benassayag et al. | Jun 2013 | A1 |
20130255702 | Griffith, Jr. et al. | Oct 2013 | A1 |
20130312742 | Monsees et al. | Nov 2013 | A1 |
20140041655 | Barron et al. | Feb 2014 | A1 |
20140060552 | Cohen | Mar 2014 | A1 |
20140345631 | Bowen et al. | Nov 2014 | A1 |
20140366898 | Monsees et al. | Dec 2014 | A1 |
20140378790 | Cohen | Dec 2014 | A1 |
20150150308 | Monsees et al. | Jun 2015 | A1 |
20150208729 | Monsees et al. | Jul 2015 | A1 |
20160044967 | Bowen et al. | Feb 2016 | A1 |
20160044968 | Bowen et al. | Feb 2016 | A1 |
20160174611 | Monsees et al. | Jun 2016 | A1 |
20160345631 | Monsees et al. | Dec 2016 | A1 |
20190289916 | Bowen et al. | Sep 2019 | A1 |
Number | Date | Country |
---|---|---|
2641869 | May 2010 | CA |
2469408 | Jan 2014 | CA |
85106876 | Sep 1986 | CN |
1122213 | May 1996 | CN |
1233436 | Nov 1999 | CN |
1333657 | Jan 2002 | CN |
1633247 | Jun 2005 | CN |
101282660 | Oct 2008 | CN |
301472873 | Feb 2011 | CN |
302002622 | Jul 2012 | CN |
302292447 | Jan 2013 | CN |
302311408 | Jan 2013 | CN |
4200639 | Jul 1992 | DE |
19854005 | May 2000 | DE |
19854012 | May 2000 | DE |
19854009 | Apr 2001 | DE |
0283672 | Sep 1988 | EP |
0295122 | Dec 1988 | EP |
0311581 | Apr 1989 | EP |
0352107 | Jan 1990 | EP |
0358002 | Mar 1990 | EP |
0358114 | Mar 1990 | EP |
0430559 | Jun 1991 | EP |
0503767 | Sep 1992 | EP |
0509657 | Oct 1992 | EP |
0532194 | Mar 1993 | EP |
0535695 | Apr 1993 | EP |
0845220 | Jun 1998 | EP |
1093936 | Apr 2001 | EP |
1458388 | Sep 2004 | EP |
2022349 | Feb 2009 | EP |
2022350 | Feb 2009 | EP |
2152313 | Feb 2010 | EP |
2319934 | May 2011 | EP |
1983851 | Aug 2011 | EP |
2772148 | Sep 2014 | EP |
3214957 | Feb 2019 | EP |
2118034 | Sep 1998 | ES |
2654002 | May 1991 | FR |
1025630 | Apr 1966 | GB |
1065678 | Apr 1967 | GB |
1213318 | Nov 1970 | GB |
S20050051 | Feb 2005 | IE |
S20050563 | Aug 2005 | IE |
S20050615 | Sep 2005 | IE |
S5434000 | Mar 1979 | JP |
61108364 | May 1986 | JP |
62278975 | Dec 1987 | JP |
6437276 | Feb 1989 | JP |
2124082 | May 1990 | JP |
02-145179 | Jun 1990 | JP |
03049671 | Apr 1991 | JP |
H0390163 | Apr 1991 | JP |
03180166 | Jun 1991 | JP |
05115272 | May 1993 | JP |
1993115272 | May 1993 | JP |
H6-114105 | Apr 1994 | JP |
09-075058 | Mar 1997 | JP |
H0975058 | Mar 1997 | JP |
10-501999 | Feb 1998 | JP |
11178563 | Jun 1999 | JP |
H11-164679 | Jun 1999 | JP |
2000203639 | Jul 2000 | JP |
2000236865 | Sep 2000 | JP |
2001165437 | Jun 2001 | JP |
1991232481 | Oct 2001 | JP |
2002529111 | Sep 2002 | JP |
2005034021 | Feb 2005 | JP |
2005506080 | Mar 2005 | JP |
2006504430 | Feb 2006 | JP |
2006064089 | Mar 2006 | JP |
2009502136 | Jan 2009 | JP |
2009509523 | Mar 2009 | JP |
54-34000 | Mar 2014 | JP |
2016539545 | Dec 2016 | JP |
0193885 | Jun 1999 | KR |
100193885 | Jun 1999 | KR |
20090010954 | Jan 2009 | KR |
WO-9406314 | Mar 1994 | WO |
WO-9501137 | Jan 1995 | WO |
WO-9712639 | Apr 1997 | WO |
WO-9911311 | Mar 1999 | WO |
WO-0028842 | May 2000 | WO |
WO-0182725 | Nov 2001 | WO |
WO-2003056949 | Jul 2003 | WO |
WO-03056948 | Jul 2003 | WO |
WO-03070031 | Aug 2003 | WO |
WO-03082031 | Oct 2003 | WO |
WO-03094900 | Nov 2003 | WO |
WO-03103387 | Dec 2003 | WO |
WO-2004041006 | May 2004 | WO |
WO-2004064548 | Aug 2004 | WO |
WO-2004076289 | Sep 2004 | WO |
WO-2004080216 | Sep 2004 | WO |
WO-2005020726 | Mar 2005 | WO |
WO-2005106350 | Nov 2005 | WO |
WO-2006004646 | Jan 2006 | WO |
WO-2006015070 | Feb 2006 | WO |
WO-2006021153 | Mar 2006 | WO |
WO-2006026637 | Mar 2006 | WO |
WO-2006082571 | Aug 2006 | WO |
WO-2007012007 | Jan 2007 | WO |
WO-2007026131 | Mar 2007 | WO |
WO-2007039794 | Apr 2007 | WO |
WO-2007042941 | Apr 2007 | WO |
WO-2007078273 | Jul 2007 | WO |
WO-2007095109 | Aug 2007 | WO |
WO-2008077271 | Jul 2008 | WO |
WO-2009079641 | Jun 2009 | WO |
WO-2010023561 | Mar 2010 | WO |
WO-2012134380 | Oct 2012 | WO |
WO-2013025921 | Feb 2013 | WO |
WO-2013083631 | Jun 2013 | WO |
WO-2013088230 | Jun 2013 | WO |
WO-2013116558 | Aug 2013 | WO |
WO-2014004648 | Jan 2014 | WO |
WO-2014150245 | Sep 2014 | WO |
WO-2014159250 | Oct 2014 | WO |
WO-2014177859 | Nov 2014 | WO |
WO-2014183736 | Nov 2014 | WO |
WO-2014201432 | Dec 2014 | WO |
WO-2015084544 | Jun 2015 | WO |
WO-2015091258 | Jun 2015 | WO |
WO-2015175979 | Nov 2015 | WO |
Entry |
---|
“Substantially” entry from dictionary.com, printed from the Internet on Dec. 21, 2020. (Year: 2020). |
National Cancer Institute (NCI) Dictionary of Cancer Terms entry for “mainstream smoke”. Printed from the Internet on Aug. 26, 2021. (Year: 2021). |
“Lighter.” Merriam-Webster Online Dictionary. 2009. Merriam-Webster Online. Jun. 8, 2009 [http://www.merriam-webster.com/dictionary/lighter]. |
Australian Application 2006269882 Exam Report dated Nov. 29, 2010. |
Australian Application 2008338305 Exam Report dated Jul. 29, 2011. |
Australian Application 2008338305 Exam Report dated Mar. 20, 2013. |
Australian Application 2012202592 Exam Report dated Dec. 10, 2013. |
Baker et ., “The pyrolysis of tobacco ingredients,” J. An. Appl. Pyrolysis, vol. 71, pp. 223-311 (2004). |
Bombick, et al. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 2. In vitro toxicology of mainstream smoke condensate. Food and Chemical Toxicology. 1997; 36:183-190. |
Bombick, et al. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 3. In vitro toxicity of whole smoke. Food and Chemical Toxicology. 1998; 36:191-197. |
Borgerding, et al. Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 1. Chemical composition of mainstream smoke. Food and Chemical Toxicology. 1997; 36:169-182. |
Bowen et al.; U.S. Appl. No. 14/960,259 entitled “Calibrated Dose Control”, filed Dec. 4, 2015. |
Bowen et al.; U.S. Appl. No. 15/101,303 entitled “Nicotine liquid formulations for aerosol devices and methods thereof,” filed Jun. 2, 2016. |
Bowen et al.; U.S. Appl. No. 15/309,554 entitled “Systems and methods for aerosolizing a smokeable material,” filed Nov. 8, 2016. |
Burch et al.; Effect of pH on nicotine absorption and side effects produced by aerosolized nicotine; Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung; 6(1); pp. 45-52; 1993. |
Canadian Application 2,712,469 Exam Report dated Oct. 27, 2011. |
Canadian Application No. 2,616,120 Office Action dated Feb. 4, 2013. |
Canadian Application No. 2,616,120 Office Action dated Jan. 3, 2014. |
Canadian Patent Application 153084 Office action dated Mar. 27, 2014. |
Canadian Patent Application 2,712,469 Office Action dated Dec. 18, 2013. |
Canadian Patent Application 2,712,469 Office Action dated Jul. 4, 2012. |
Canadian Patent Application 2,712,469 Office Action dated May 16, 2013. |
Canadian Patent Application 2,712,469 Office Action dated Oct. 27, 2011. |
Chinese Patent Application 200680026317 Office Action dated Jan. 31, 2012. |
Chinese Patent Application 200680026317 Office Action dated Aug. 27, 2012. |
Chinese Patent Application 200680026317.6 Office Action dated Jan. 26, 2014. |
Chinese Patent Application 200680026317.6 Office Action dated Oct. 8, 2013. |
Chinese Patent Application 200680026317.6 Rejection Decision dated Dec. 24, 2012 (English Translation Only). |
Chinese Patent Application 200880126977 Office Action dated Aug. 28, 2012. |
Chinese Patent Application 200880126977 Office Action dated Dec. 11, 2013. |
Chinese Patent Application 200880126977 Office Action dated May 29, 2013. |
Chinese Patent Application 201210129768 Office Action dated Feb. 25, 2014. |
Davis & Nielsen, “Marketing, Processing and Storage: Green Leaf Threshing and Redrying Tobacco,” Tobacco Production, Chemistry and Technology, (1999) Section 10B, pp. 330-333, Bill Ward, Expert Leaf Tobacco Company, Wilson, North Carolina, A. |
European Application No. 06787864.5 Exam Report dated Nov. 12, 2013. |
European Application No. 06787864.5 Extended European Search Report dated Mar. 22, 2013. |
European Application No. 08860921.9 Extended Search Report dated Oct. 10, 2013. |
European Application No. 13189967.6 Search Report dated Jun. 13, 2014. |
European Application No. 14153321.6 Communication dated Jan. 28, 2015. |
European Application No. 14153321.6 Office action dated May 22, 2014. |
European Application No. 14153321.6 Search report dated May 9, 2014. |
European Application No. 14153323.2 Communication dated Jan. 29, 2015. |
European Application No. 14153323.2 Office action dated May 22, 2014. |
European Application No. 14153323.2 Search report dated May 9, 2014. |
European Application No. 14153324.0 Office action dated May 22, 2014. |
European Application No. 14153324.0 Search report dated May 9, 2014. |
European Application No. 14153325.7 Search report dated Jun. 20, 2014. |
European Application No. 14153326.5 Communication dated Jan. 29, 2015. |
European Application No. 14153326.5 Office action dated May 27, 2014. |
European Application No. 14153326.5 Search Report dated May 9, 2014. |
European Application No. 14153327.3 Communication dated Jan. 30, 2015. |
European Application No. 14153327.3 Office action dated Jun. 27, 2014. |
European Application No. 14153327.3 Search report dated May 26, 2014. |
European Application No. 14153340.6 Search report and search opinion dated Oct. 8, 2014. |
European Patent Application 06787864.5 Exam Report dated Apr. 2, 2013. |
European Patent Application 06787864.5 Exam Report dated Nov. 12, 2013. |
European Patent Application 06787864.5 Extended European Search Report completed Mar. 22, 2013. |
European Patent Application 08860921.9 Extended Search Report dated Oct. 10, 2013. |
European Patent Application No. 12824116.3 Extended European Search Report dated Mar. 4, 2015. |
European Patent Application No. 14153325.7 Office Action dated Feb. 23, 2015. |
European search report and search opinion dated Oct. 8, 2014 for EP Application No. 14153340.6. |
European search report dated May 9, 2014 for EP Application No. 14153321.6. |
European search report dated May 9, 2014 for EP Application No. 14153323.2. |
European search report dated May 9, 2014 for EP Application No. 14153324.0. |
European search report dated May 9, 2014 for EP Application No. 14153326.5. |
European search report dated May 26, 2014 for EP Application No. 14153327.3. |
European Search Report dated Jun. 13, 2014 for EP Application No. 13189967.6. |
European search report dated Jun. 20, 2014 for EP Application No. 14153325.7. |
Food & Drug Administration; Warning letter to The Compounding Pharmacy; retrieved Oct. 10, 2014 from http://www.fda.gov/ICECI/EnfocementActions/WarningLetters/2002/ucm144843.-htm; 3 pgs.; Apr. 9, 2002. |
Grotenhermen et al.; Developing science-based per se limits fordriving under the influence of cannabis (DUIC): findings and recommendations by an expertpanel; retrieved Feb. 9, 2017 from (http://www.canorml.org/healthfacts/DUICreport.2005.pdf); 49 pages; Sep. 2005. |
Harvest Vapor; American Blend Tobacco (product info.); retrieved from the internet (http://harvestvapor.com/); 2 pgs.; print/retrieval date: Oct. 10, 2014. |
Hatton et al.; U.S. Appl. No. 15/396,584 entitled “Leak-resistant vaporizer cartridges for use with cannabinoids,” filed Dec. 31, 2016. |
Inchem; Benzoic Acid; JECFA Evaluation Summary; retrieved Oct. 10, 2014 from http://www.inchem.org/documents/jecfa/feceval/jec_184.htm; 2 pgs..; May 28, 2005. |
Inchem; Levulinic Acid; JECFA Evaluation Summary; retrieved Oct. 10, 2014 from http://www.inchem.org/documents/jecfa/feceval/jec_1266.htm; 1 pg.; Mar. 10, 2003. |
Inchem; Pyruvic Acid; JECFA Evaluation Summary; retrieved Oct. 10, 2014 from http://www.inchem.org/documents/jecfa/feceval/jec_2072.htm; 1 pg.; Jan. 29, 2003. |
Inchem; Sorbic Acid; JECFA Evaluation Summary; retrieved Oct. 10, 2014 from http://www.inchem.org/documents/jecfa/feceval/jec_2181.htm; 1 pg.; May 29, 2005. |
Ingebrethsen et ., “Electronic Cigarette aerosol particle size distribution measurements”, Inhalation Toxicology, 2012; 24 (14): 976-984. |
Japanese Patent Application 2008-522926 Exam Report dated Nov. 29, 2011. |
Japanese Patent Application 2010-539818 dated Mar. 24, 2014. |
Japanese Patent Application 2010-539818 Notification of Reasons for Ref dated Apr. 23, 2013(English Translation Only). |
Japanese Patent Application 2012-106389 Office Action dated Sep. 24, 2013. |
Korean Patent Application 10-2008-7003419 Office Action dated Feb. 7, 2013 (English Translation Only). |
Korean Patent Application 10-2008-7003419 Office Action dated Nov. 25, 2013. |
Korean Patent Application 10-2010-70160 Office Action dated May 8, 2012. |
Korean Patent Application 10-2010-7016086 Fin Rejection dated Dec. 30, 2013. |
Korean Patent Application 10-2010-7016086 Office Action dated Mar. 25, 2013 (English Translation Only). |
Korean Patent Application 10-2010-7016086 Office Action dated May 8, 2012 (non-English and English translation). |
Kuo et al. Applications of Turbulent and Multiphase Combustion, Appendix D: Particle Size—U.S. Sieve Size and Tyler Screen Mesh Equivalents, 2012, p. 541-543. |
McCann et al., “Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: discussion.” Proct. Nat. Acad. Sci, USA, Mar. 1976, vol. 73 (3), 950954. |
Monsees et al.; U.S. Appl. No. 15/165,954 entitled “Devices for vaporization of a substance,” filed May 26, 2016. |
Monsees et al.; U.S. Appl. No. 15/165,972 entitled “Portable devices for generating an inhalable vapor,” filed May 26, 2016. |
Monsees et al.; U.S. Appl. No. 15/166,001 entitled “Electronic vaporization device,” filed May 26, 2016. |
Monsees et al.; U.S. Appl. No. 15/257,748 entitled “Cartridge for use with a vaporizer device,” filed Sep. 6, 2016. |
Monsees et al.; U.S. Appl. No. 15/257,760 entitled “Vaporizer apparatus,” filed Sep. 6, 2016. |
Monsees et al.; U.S. Appl. No. 15/257,768 entitled “Vaporizer apparatus,” filed Sep. 6, 2016. |
Monsees et al.; U.S. Appl. No. 15/261,823 entitled “Low temperature electronic vaporization device and methods,” filed Sep. 9, 2016. |
Monsees et al.; U.S. Appl. No. 15/368,539 entitled “Low temperature electronic vaporization device and methods,” filed Dec. 2, 2016. |
Monsees et al.; U.S. Appl. No. 15/379,898 entitled “Vaporization device systems and methods,” filed Dec. 15, 2016. |
Monsees, J.; U.S. Appl. No. 12/115,400 entitled “Method and System for Vaporization of a Substance”, filed May 5, 2008. |
Nicoli et al., Mammalian tumor xenografts induce neovascularization in Zebrafish embryos. Cancer Research, 67:2927-2931 (2007). |
Notice of Allowance dated Aug. 18, 2014 for U.S. Appl. No. 12/482,376. |
Notice of Allowance dated Sep. 11, 2014 for U.S. Appl. No. 12/482,379. |
Office action dated Jun. 20, 2014 for KR Application No. 10-2010-7016086. |
Office action dated Jul. 9, 2014 for U.S. Appl. No. 11/485,168. |
PCT(2012/051165 International Search Report and Written Opinion dated Oct. 25, 2012. |
PCT/IB2006/002040 International Preliminary Report on Patentability dated Apr. 1, 2008. |
PCT/IB2006/002040 International Search Report and Written Opinion dated Mar. 26, 2007. |
PCT/IB2006/003842 International Preliminary Report on Patentability dated Apr. 1, 2008. |
PCT/IB2006/003842 International Search Report and Written Opinion dated May 31, 2007. |
PCT/US06/28039 Corrected Written Opinion dated Dec. 20, 2007. |
PCT/US06/28039 International Search Report dated Sep. 6, 2007. |
PCT/US06/28039 IPER and Written Opinion dated Jul. 15, 2008. |
PCT/US08/87488 IPER and Written Opinion dated Jun. 22, 2010. |
PCT/US2008/87488 International Search Report dated Jul. 13, 2009. |
PCT/US2008/87488 Written Opinion dated Jul. 13, 2009. |
PCT/US2012/051165 International Preliminary Report on Patentability dated Feb. 18, 2014. |
PCT/US2012/051165 International Search Report and Written Opinion dated Oct. 25, 2012. |
PCT/US2014/042425 International Search Report and Written Opinion dated Nov. 3, 2014. |
Perfetti; Structural study of nicotine salts; Beitrage zur Tabakforschung International; Contributions to Tobacco Research; 12(2); pp. 43-54; Jun. 1983. |
Seeman et al.; The form of nicotine in tobacco. Thermal transfer of nicotine and nicotine acid salts to nicotine in the gas phase; J Aric Food Chern.; 47(12); pp. 5133-5145; Dec. 1999. |
Torikai et al., “Effects of temperature, atmosphere and pH on the generation of smoke compounds during tobacco pyrolysis,” Food and Chemical Toxicology 42 (2004) 1409-1417. |
TW 097149447 Office Action dated Nov. 11, 2013. |
U.S. Appl. No. 11/485,168 Office Action dated Aug. 3, 2010. |
U.S. Appl. No. 11/485,168 Office action dated Dec. 21, 2012. |
U.S. Appl. No. 11/485,168 Office Action dated Feb. 4, 2010. |
U.S. Appl. No. 11/485,168 Office action dated Jul. 9, 2014. |
U.S. Appl. No. 11/485,168 Office Action dated Jun. 23, 2009. |
U.S. Appl. No. 11/485,168 Office action dated Mar. 27, 2014. |
U.S. Appl. No. 11/485,168 Office Action dated Nov. 3, 2009. |
U.S. Appl. No. 11/485,168 Office action dated Sep. 5, 2013. |
U.S. Appl. No. 12/336,439 Final Action dated Nov. 25, 2013. |
U.S. Appl. No. 12/336,439 Final Office Action dated Feb. 1, 2012. |
U.S. Appl. No. 12/336,439 Office Action dated Aug. 17, 2011. |
U.S. Appl. No. 12/336,439 Office action dated Aug. 6, 2014. |
U.S. Appl. No. 12/336,439 Office Action dated Feb. 22, 2013. |
U.S. Appl. No. 12/336,439 Office Action dated Feb. 28, 2014. |
U.S. Appl. No. 12/482,379 Final Office Action dated Sep. 5, 2012. |
U.S. Appl. No. 12/482,379 Non Final Office Action dated Dec. 17, 2013. |
U.S. Appl. No. 12/482,379 Office Action dated Dec. 22, 2011. |
U.S. Appl. No. 13/587,416 Office Action dated Feb. 2, 2015. |
U.S. Appl. No. 13/587,416 Office Action dated Oct. 31, 2014. |
U.S. Appl. No. 29/446,987 Office Action dated Nov. 13, 2014. |
Wells. “Glycerin as a Constituent of Cosmetics and Toilet Preparations.” Journal of the Society of Cosmetic Chemists,1958; 9(1): 19-25. |
“Chapter 8: Basic Chemical Constituents of Tobacco Leaf and Differences among Tobacco Types”, JC Leffingwell et al, Tobacco: Production, Chemistry and Technology, Blackwell Science, (19990000), pp. 265-284. |
Clayton et al., “Spectroscopic investigations into the acid-base properties of nicotine at different temperatures”, (2013). |
Henningfield et al., “Tobacco Control”, 1995; 4; 57-61 (1995). |
Keithly L. et al., “Industry research on the use and effects of levulinic acid: a case study in cigarette additives”, Nicotine & Tobacco Research, (20051000), vol. 7, No. 5, pp. 761-771. |
RJR; Alarie, Y., “New Cigarette Prototypes That Heat Instead of Burn Tobacco”, Chemical and Biological Studies on New Cigarette Prototypes that Heat instead of Burn Tobacco. 1988, RJ Reynolds Records; Master Settlement Agreement. |
Stepanov I. et al., “Bringing attention to e-cigarette pH as an important element for research and regulation”, Tob Control, (201407), vol. 24, No. 4, pp. 413-414, XP055656377. |
Intorp et al. (May 1, 2009) “Determination of “Hoffmann Analytes” in Cigarette Mainstream Smoke. The Coresta 2006 Joint Experiment”, Beitrage Zur Tabakforschung International/Contributions to Tobacco Research, 23 (4), 161-202. |
Number | Date | Country | |
---|---|---|---|
20190261686 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
61014690 | Dec 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14625042 | Feb 2015 | US |
Child | 16264260 | US | |
Parent | 12336439 | Dec 2008 | US |
Child | 14625042 | US |